Logout

Do you really want to logout?

Forgot Password

Email information
Please enter your email address and we will send you instructions to set a new password.

Choose / Confirm new Password

Choose / Confirm new Password

My DLD - Create Account


or
or

To link your Twitter account with your DLD profile, we need you to enter your DLD Email and Password. You only do this once.

Login Credentials

To link your Facebook account with your DLD profile, we need you to enter your DLD Email and Password. You only do this once.

Login Credentials
Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more
Marc Koska
http://s3.amazonaws.com/dldwebsite-production/black_and_white_avatars/marc-koska/pulse/open-uri20121220-19865-1kx8fid
ApiJect
mock full_address

Marc Koska

Marc Koska

NextSEE ALL DLD SPEAKERS
Marc Koska

Marc Koska

was speaking at DLD17

Star top

Marc Koska
Company: ApiJect
Title: Founder
Location: East Sussex, United Kingdom
Fields of operation: Life & Health

I founded ApiJect, a group of new technology to increase efficiencies in delivering health globally.

In 1984, Marc Koska, the founder of Apiject K7, sought to address the widespread problem of cross-contamination through the re-use of syringes and needles which frequently results in fatalities and increased disease. To date, over 6 billion of his resulting first design - the K1 - syringes have been sold, likely saving over 5 million lives. In 2006 Marc established the Safepoint Trust whose goal is to inform the next generation about safer injections. Marc recognised that educating the world about the dangers of re-using syringes was an essential part of reducing death and infection from cross infection and contamination.

While the K1 syringe successfully made the administration of vaccines and all drugs safer, through its revolutionary cost-effective Auto-Disable feature, his newest design the K7 takes a more holistic view of the whole process of getting a pharmaceutical drug to its delivery point – and improves it radically.


CONFERENCES AND ARTICLES

NEWSLETTER